OBE022
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OBE022, covering 2021-06-07 to 2021-06-07. Get the full timeline:
Most recent: Clinical Trial Update: PoC Study of OBE022 in Threatened Preterm Labour [Phase 2]